A. Hlobilková

发表

Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines

B. Vojtesek, P. Murray, M. Hajdúch, 2002, Molecular pathology : MP.

The mechanism of action of the tumour suppressor gene PTEN.

J. Bartek, J. Lukas, Z. Kolár̂, 2003, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity.

J. Bartek, J. Lukas, P. Guldberg, 2000, Experimental cell research.

Nestin expression in cutaneous melanomas and melanocytic nevi

A. Hlobilková, T. Brychta, M. Fiurásková, 2007, Journal of cutaneous pathology.

Molecular changes in PDEGF and bFGF in malignant melanomas in relation to the stromal microenvironment.

Z. Kolár̂, M. Tichý, P. Beneš, 2005, Anticancer research.

Synthesis and biological activity of 8-azapurine and pyrazolo[4,3-d]pyrimidine analogues of myoseverin.

M. Strnad, L. Havlícek, V. Kryštof, 2006, European journal of medicinal chemistry.

BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic.

R. Kodet, J. Dušková, J. Betka, 2010, Journal of endocrinological investigation.

The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine

J. Ulrichová, A. Zdařilová, A. Hlobilková, 2006, Cell Biology and Toxicology.

the iron transport pathway in erythroid cells Severe hypochromic microcytic anemia caused by a congenital defect of

V. Divoky, J. Prchal, D. Pospíšilová, 2011 .

Severe hypochromic microcytic anemia caused by a congenital defect of the iron transport pathway in erythroid cells.

V. Divoky, J. Prchal, V. Mihál, 2004, Blood.

Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression.

O. Kalita, Z. Kolár̂, J. Ehrmann, 2009, Neoplasma.

Triple negative breast cancer - BCL2 in prognosis and prediction. Review.

J. Bouchal, J. Vrbková, A. Hlobilková, 2014, Current drug targets.

The Tumor Suppressor Gene PTEN Plays a Role in Cell Cycle Regulation and Apoptosis in Prostate Cancer Cell Lines

P. Guldberg, Z. Kolár̂, A. Hlobilková, 2005 .

Induction of apoptosis and regression of spontaneous dog melanoma following in vivo application of synthetic cyclin-dependent kinase inhibitor olomoucine.

M. Strnad, V. Mihál, Z. Kolár̂, 1997, Anti-cancer drugs.

The effects of natural ligands of hormone receptors and their antagonists on telomerase activity in the androgen sensitive prostatic cancer cell line LNCaP.

J. Bouchal, Z. Kolár̂, J. Mad'arová, 2002, Biochemical pharmacology.

Glioblastoma multiforme with an abscess: case report and literature review

O. Kalita, J. Ehrmann, A. Hlobilková, 2008, Journal of Neuro-Oncology.

Immunohistochemical assessment of E-cadherin and beta-catenin in trichofolliculomas and trichoepitheliomas.

Z. Kolár̂, A. Hlobilková, T. Brychta, 2007, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis.

Alice Hlobilkova, A. Zdařilová, A. Hlobilková, 2006, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas

J. Bartek, J. Lukas, J. Bártková, 2010, Oncogene.

Autocrine regulation of glioblastoma cell-cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay

J. Bartek, O. Kalita, Z. Kolár̂, 2008, Cell cycle.

Differences in p53 and Bcl-2 expression in relation to cell proliferation during the development of human embryos.

R. Nenutil, B. Vojtesek, P. Murray, 1998, Molecular pathology : MP.

The significance of key regulators of apoptosis in the development and prognosis of prostate carcinoma. II. Products of suppressor genes Rb and PTEN, CDKI, Fas.

Z. Kolár̂, A. Hlobilková, J. Knillová, 2003, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells.

Zdenek Kolar, V. Kryštof, Z. Kolár̂, 2006, Anticancer research.

The expression of apoptosis-related proteins and the apoptotic rate in glial tumors of the brain.

Z. Kolár̂, J. Ehrmann, M. Kala, 2000, Neoplasma.

Oligodendroglia from ADSL-deficient patient produce SAICAribotide and SAMP.

J. Zeman, S. Kmoch, D. Friedecký, 2010, Molecular genetics and metabolism.

BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic

R. Kodet, J. Dušková, J. Betka, 2010, Journal of endocrinological investigation.

Synergic effects of the cyclin-dependent kinase (CDK) inhibitor olomoucine and androgen-antagonist bicalutamide on prostatic cancer cell lines.

M. Strnad, J. Bouchal, Z. Kolár̂, 2004, Neoplasma.

Androgen sensitivity related proteins in hormone-sensitive and hormone-insensitive prostate cancer cell lines treated by androgen antagonist bicalutamide.

P. Murray, Z. Kolár̂, M. Lukešová, 2001, Neoplasma.

Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?

O. Kalita, Z. Kolár̂, J. Ehrmann, 2007, Neoplasma.